» Articles » PMID: 35305609

Understanding Barriers to and Strategies for Medication Adherence in COPD: a Qualitative Study

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2022 Mar 20
PMID 35305609
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Medication adherence in chronic obstructive pulmonary disease (COPD) is low, though not enough is known about the factors that affect adherence in COPD. This study uses qualitative methods to understand the patient perspective on facilitators and barriers to medication adherence in COPD as well as patient-reported strategies for self-management of disease.

Methods: Semi-structured interviews were conducted with 30 individuals (n = 30). Transcripts were analyzed using iterative qualitative coding by 2 independent coders, and codes were categorized using thematic analysis.

Results: Challenges with adherence reported were gaps in understanding, forgetfulness of the patient, physician availability, cost navigation, and overcoming substance use. Most commonly, the financial burden of COPD medications caused patients to source other countries to obtain medications, rely on sample medications collected during doctors' visits, and to alter medication dosage and frequency to extend the length of a prescription. Tools and resources reported by patients to support self-management of COPD included pharmacist assistance, physician office information, and community resources. Individuals further reported that the use of logs or diaries to track medication usage, visual or temporal cues to take medications, and support from family members were helpful in promoting adherence to their COPD medication regimen.

Conclusions: Medication adherence in individuals with COPD is affected by challenges with self-management of disease and financial burden of medications. However, patients reported multiple tools and resources to support adherence. Physician recognition of these factors impacting self-management, as well as awareness of strategies to promote adherence and manage disease, may improve patient outcomes.

Citing Articles

Barriers and facilitators of adherence to treatment interventions for COPD amongst individuals from minority ethnic communities: Meta-ethnography.

Alamer S, Robinson-Barellla A, Cooper M, Nazar H, Husband A PLoS One. 2025; 20(2):e0318709.

PMID: 39928635 PMC: 11809908. DOI: 10.1371/journal.pone.0318709.


Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.

Mannino D, Weng S, Germain G, Boudreau J, Tardif-Samson A, Forero-Schwanhaeuser S Adv Ther. 2024; 42(2):1131-1146.

PMID: 39731707 PMC: 11787206. DOI: 10.1007/s12325-024-03088-1.


Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study.

Joksaite S, Wood R, Ismaila A, Camidge L, Mizukami A, Czira A BMJ Open. 2024; 14(12):e080864.

PMID: 39632104 PMC: 11624741. DOI: 10.1136/bmjopen-2023-080864.


Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.

Roman-Rodriguez M, McMullan I, Warner M, Compton C, Tal-Singer R, Orlow J Patient Prefer Adherence. 2024; 18:2295-2306.

PMID: 39559482 PMC: 11571923. DOI: 10.2147/PPA.S467870.


Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes.

Mannino D, DiRocco K, Germain G, Laliberte F, Noorduyn S, Urosevic A Adv Ther. 2024; 41(12):4557-4580.

PMID: 39453592 PMC: 11550231. DOI: 10.1007/s12325-024-02999-3.


References
1.
Castaldi P, Rogers W, Safran D, Wilson I . Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. Chest. 2010; 138(3):614-20. PMC: 2940068. DOI: 10.1378/chest.09-3031. View

2.
Petersen R, Lopez O, Armstrong M, Getchius T, Ganguli M, Gloss D . Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017; 90(3):126-135. PMC: 5772157. DOI: 10.1212/WNL.0000000000004826. View

3.
Francis J, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles M . What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010; 25(10):1229-45. DOI: 10.1080/08870440903194015. View

4.
Vrijens B, de Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T . A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5):691-705. PMC: 3403197. DOI: 10.1111/j.1365-2125.2012.04167.x. View

5.
Philip K, Gaduzo S, Rogers J, Laffan M, Hopkinson N . Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport. BMJ Open Respir Res. 2019; 6(1):e000478. PMC: 6797266. DOI: 10.1136/bmjresp-2019-000478. View